Autonomic effects of selegiline: possible cardiovascular toxicity in Parkinson's disease

J Neurol Neurosurg Psychiatry. 1998 Aug;65(2):280; author reply 281-2.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Aged
  • Antiparkinson Agents / adverse effects*
  • Antiparkinson Agents / therapeutic use
  • Autonomic Nervous System Diseases / chemically induced*
  • Blood Pressure / drug effects
  • Cardiovascular System / innervation*
  • Drug Therapy, Combination
  • Female
  • Heart Rate / drug effects
  • Humans
  • Levodopa / adverse effects
  • Levodopa / therapeutic use
  • Male
  • Middle Aged
  • Parkinson Disease / drug therapy*
  • Selegiline / adverse effects*
  • Selegiline / therapeutic use
  • Valsalva Maneuver / drug effects

Substances

  • Antiparkinson Agents
  • Selegiline
  • Levodopa